Friday, November 21, 2008 - 6:12PM EST

General Interest Articles

21. Immunogenicity of influenza vaccination in patients with non-hodgkin lymphoma.

Author
Centkowski P; Brydak L; Machala M; Kalinka-Warzocha E; Blasinska-Morawiec M; Federowicz I; Walewski J; Wc E Grzyn J; Wolowiec D; Lech-Maranda E; Sawczuk-Chabin J; Bilinski P; Warzocha K;
Institution
Department of Hematology, Institute of Hematology and Transfusion Medicine, I. Gandhi Street 14, 02776, Warsaw, Poland.
Journal
J Clin Immunol. 2007 May;27(3):339-46. Epub 2007 Mar 8.
Abstract URL
Click here to view abstract

22. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma.

Author
Hartge P; Smith MT;
Institution
National Cancer Institute, NIH, Department of Health and Human Services, Rockville, MD 20892, USA. hartge@nih.gov
Journal
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):367-8. Epub 2007 Mar 7.

23. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

Author
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC;
Institution
EORTC Data Centre, Brussels, Belgium. e.c.moser@lumc.nl
Journal
Haematologica. 2006 Nov;91(11):1481-8. Epub 2006 Oct 17.
Abstract URL
Click here to view abstract

24. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.

Author
Maule M; Scelo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P;
Institution
Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, CPO Piemonte, CeRMS, University of Turin, Via Santena 7, 10126, Turin, Italy. milena.maule@unito.it
Journal
J Natl Cancer Inst. 2007 May 16;99(10):790-800.
Abstract URL
Click here to view abstract

25. Obesity and risk of non-Hodgkin lymphoma (United States).

Author
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD;
Institution
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Suite 1102, Chicago, IL, 60611-4402, USA.
Journal
Cancer Causes Control. 2007 May 7;.
Abstract URL
Click here to view abstract

26. Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials.

Author
Rafailidis PI; Kakisi OK; Vardakas K; Falagas ME;
Institution
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.
Journal
Cancer. 2007 Apr 11;.
Abstract URL
Click here to view abstract

27. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.

Author
Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H;
Institution
Department of Pediatric Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
Journal
Pediatr Blood Cancer. 2007 Apr 9;.
Abstract URL
Click here to view abstract

28. The role of FDG PET in the management of lymphoma: what is the evidence base?

Author
Kirby AM; Mikhaeel NG;
Institution
Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK. annakirby@doctors.org.uk
Journal
Nucl Med Commun. 2007 May;28(5):335-54.
Abstract URL
Click here to view abstract

29. Predicting the outcome in non-Hodgkin lymphoma with molecular markers.

Author
Kwong YL;
Institution
Department of Medicine, University of Hong Kong, Hong Kong, China.
Journal
Br J Haematol. 2007 May;137(4):273-87. Epub 2007 Apr 4.
Abstract URL
Click here to view abstract

30. Survival from adolescent cancer.

Author
Desandes E;
Institution
French National Registry of Childhood Solid Tumours, Universite Henri Poincare Nancy 1, Faculte de Medecine, 9, Avenue de la Foret de Haye, BP 184, 54505 Vandoeuvre-les-Nancy cedex, France.
Journal
Cancer Treat Rev. 2007 Mar 28;.
Abstract URL
Click here to view abstract
Pages: 1 2 3